Browsing by Author Powell, E

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)Citation
2013CCR5-Delta32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infectionAhlenstiel, Golo; Booth, David; George, Jacob; O'Connor, Kate; Stewart, Graeme; Suppiah, Vijayaprakash; Abate, Maria; Armstrong, Nicola; Bassendine, Maragaret; Berg, T; Dore, GJ; et al, Various; Irving, William; Mueller, Tobias; Nattermann, J; Powell, E; Riordan, Stephen; Spengler, Ulrich; Weltman, Martin; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstituteCCR5-Delta32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection, Genes and Immunity, vol.14, 5, 2013,pp 286-290
2010Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)--results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive carePavlakis, Nick; Asmis, T; Dueck, D; Gibbs, Peter; Jeffery, M; Jonker, D; Karapetis, Christos; Langer, Christine; O’Callaghan, C; Powell, E; Tu, D.; Whittom, R; Zhu, L; Northern Clinical School: MedicineComorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)--results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care, Annals of Oncology, vol.22, 1,pp 118-126